"Immunoassay Market By Products and Services (Instruments, Reagents & Kits, Software & Services), By Applications (Oncology, Infectious Disease Testing, Cardiology, Endocrinology, Autoimmune Disease, Other Applications), By End-users, By Regions – Global F" report has been added to ResearchAndMarkets.com’s offering.” data-reactid=”12″>The “Immunoassay Market By Products and Services (Instruments, Reagents & Kits, Software & Services), By Applications (Oncology, Infectious Disease Testing, Cardiology, Endocrinology, Autoimmune Disease, Other Applications), By End-users, By Regions – Global F” report has been added to ResearchAndMarkets.com’s offering.
The author’s market research report predicts that the global immunoassay market will grow at a CAGR of ~6.0% during the forecast period 2019-2025.
Growing patient base, improvements in technology, increasing significance of companion diagnostics in the immunoassay market, launch of innovative products, and rising elderly population are few of the factors facilitating the growth of the immunoassay market.
The market continues to grow as immunoassay is one of the most widely used techniques for disease diagnosis and measuring treatment effectiveness. Key market players are focusing on increased product launch and strategic deals to strengthen their market position.
According to the author analysis, North America accounted for the largest share of the global immunoassay market in 2018 and Asia Pacific is expected to grow at a high CAGR during the forecast period. Immunoassays offer a broad array of applications in disease diagnosis with high specificity and sensitivity when compared to other tests. According to the National Cancer Institute, in the US, an estimated 1,735,530 new cancer cases were diagnosed and approximately 609,640 deaths were recorded in 2018. The biggest infectious disease killers, currently in the US, are pneumonia and flu, which are responsible for nearly 40% of all deaths from infectious diseases.
The market is growing at a steady rate with mid-single-digit CAGR during the forecast period 2019-2025. The market players are continuously focusing on R&D to deliver innovative products in the market. The increasing usage of technology has resulted in strategic collaborations, new product launch, and increased funding. For instance, in March 2019, Beckman Coulter announced the launch of Access PCT assay, the newest addition to its extensive portfolio for the sepsis identification and management. In April 2019, Thermo Fisher Scientific announced the availability of the new immunoassay, Thermo Scientific CEDIA Mitragynine (Kratom) assay, its latest drugs of abuse test that comprises supporting calibrators and controls. In August 2019, Bio-Techne Corporation and Cygnus Technologies, a part of Maravai LifeSciences, announced a strategic partnership for the quantification of Chinese Hamster Ovary Host Cell Proteins (CHO-HCP) on the ProteinSimple-branded Ella immunoassay platform. According to agreement terms, both the companies are introducing the co-developed third-generation CHO-HCP assay in the proprietary Simple Plex immunoassay cartridge for customers in North America and Europe.
The report provides complete details about the sub-segments of the global immunoassay market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the diagnostics segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth.
1.1 Industry Overview
1.2 Total Addressable Market
1.3 Industry Trends
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market
3.3 Industry Trends
3.4 Related Market
3.4.1 Point-of-Care Diagnostics
4.1 Funding Scenario
4.2 Market Segmentation
4.3 Porter 5 (Five) Forces
4.4 PEST Analysis
5.1 Market Dynamics
126.96.36.199 Growing incidence of chronic and infectious disease
188.8.131.52 Increase in geriatric population
184.108.40.206 Growing adoption of immunoassay-based point-of-care diagnostics
220.127.116.11 Stringent regulatory approval process of immunoassay instruments and consumables
18.104.22.168 Unfavorable reimbursement scenario
22.214.171.124 Growing importance of companion diagnostics in the immunoassay market
126.96.36.199 Market expansion opportunities in emerging economies
5.1.4 DRO – Impact Analysis
5.2 Key Stakeholders
6.3 Reagents and Kits
6.4 Software & Services
7.3 Infectious Disease Testing
7.6 Autoimmune Disease
7.7 Other Applications
8.2 Hospitals and Laboratories
8.3 Pharmaceutical and Biotechnology Companies
8.4 Other End-users
9.2 North America
9.4 Asia Pacific
9.5 Rest of the World
11.1 Roche Diagnostics
11.2 bioMrieux SA
11.3 Abbott Laboratories
11.4 Becton Dickinson & Company
11.5 Siemens Healthineers
12.1 Danaher Corporation
12.2 Sysmex Corporation
12.3 Ortho Clinical Diagnostics
12.4 Thermo Fisher Scientific Inc.
12.5 Quidel Corporation
12.7 Bio-Rad Laboratories
https://www.researchandmarkets.com/r/rearch” data-reactid=”118″>For more information about this report visit https://www.researchandmarkets.com/r/rearch